Hyperion Therapeutics Inc (NASDAQ:HPTX)

30.17
Delayed Data
As of Mar 02
 +0.62 / +2.10%
Today’s Change
20.23
Today|||52-Week Range
31.31
+25.71%
Year-to-Date

Today’s Trading

Previous close29.55
Today’s open29.50
Day’s range-- - --
Volume438,355
Average volume (3 months)168,335
Market cap$612.4M
Dividend yield--
Data as of 03/02/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-216.25%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales9.30
Price/Book4.97

Competitors

 Today’s
change
Today’s
% change
OSIROsiris Therapeutics ...+0.11+0.64%
FPRXFive Prime Therapeut...+0.35+1.36%
IMGNImmunoGen Inc+0.29+3.82%
AERIAerie Pharmaceutical...+0.81+2.88%
Data as of 03/02/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)$0.22
Annual revenue (last year)$42.2M
Annual profit (last year)$16.6M
Net profit margin39.40%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Donald J. Santel
Chief Financial Officer &
Senior Vice President
Jeffrey S. Farrow
Corporate headquarters
Brisbane, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account